Yogen Saunthararajah Selected Research

Transplantation

1/2019	Low-Dose Azacitidine with DNMT1 Level Monitoring to Treat Post-Transplantation Acute Myelogenous Leukemia or Myelodysplastic Syndrome Relapse.
9/2004	EVI1 induces myelodysplastic syndrome in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yogen Saunthararajah Research Topics

Disease

39	Neoplasms (Cancer) 04/2024 - 05/2002
19	Sickle Cell Anemia (Hemoglobin S Disease) 09/2023 - 01/2003
18	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 08/2002
14	Leukemia 04/2024 - 07/2004
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 07/2004
5	Cytopenia 02/2015 - 01/2000
4	Hemoglobinopathies 01/2021 - 10/2010
4	Uveal melanoma 01/2019 - 07/2014
4	Thalassemia 03/2014 - 12/2003
3	Disease Progression 01/2023 - 01/2019
3	Neutropenia 01/2021 - 11/2003
3	beta-Thalassemia (Cooley's Anemia) 10/2018 - 01/2003
3	Primary Myelofibrosis (Myelosclerosis) 02/2015 - 08/2012
2	Prostatic Neoplasms (Prostate Cancer) 05/2023 - 03/2014
2	Pancytopenia 01/2022 - 01/2000
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 09/2002
2	Bone Marrow Failure Disorders 12/2021 - 08/2002
2	Multiple Myeloma 05/2021 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 02/2011
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019 - 05/2014
2	Hemolysis 09/2017 - 04/2008
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 05/2002
2	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2015
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2013 - 07/2004
2	Refractory Anemia 10/2012 - 01/2000
2	Melanoma (Melanoma, Malignant) 09/2012 - 07/2012
2	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2007 - 02/2004
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Glioma (Gliomas) 11/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2022
1	idiopathic Aplastic anemia 12/2021
1	Large Granular Lymphocytic Leukemia 09/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Ascites 01/2020

Drug/Important Bio-Agent (IBA)

25	Decitabine FDA Link 01/2024 - 01/2003
15	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 09/2004
13	Azacitidine (5 Azacytidine)FDA Link 01/2024 - 01/2003
10	MethyltransferasesIBA 01/2024 - 01/2013
10	Fetal Hemoglobin (Hemoglobin F)IBA 01/2023 - 01/2003
8	EnzymesIBA 05/2023 - 10/2012
7	Transcription Factors (Transcription Factor)IBA 11/2022 - 02/2012
6	TetrahydrouridineIBA 01/2021 - 07/2012
6	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2011
5	Hemoglobins (Hemoglobin)IBA 09/2023 - 01/2000
5	Co-Repressor ProteinsIBA 05/2023 - 06/2011
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2004
4	DeoxycytidineIBA 01/2021 - 07/2012
4	GlobinsIBA 01/2021 - 01/2003
4	Sickle HemoglobinIBA 01/2019 - 12/2003
3	CytokinesIBA 11/2022 - 09/2012
3	ChromatinIBA 11/2022 - 05/2007
3	RNA (Ribonucleic Acid)IBA 11/2022 - 05/2021
3	RNA Splicing FactorsIBA 01/2021 - 10/2012
3	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2018 - 04/2003
3	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2013 - 12/2010
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2003 - 01/2000
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2003 - 01/2000
2	Immune Checkpoint InhibitorsIBA 01/2023 - 04/2019
2	ChemokinesIBA 11/2022 - 01/2019
2	DioxygenasesIBA 01/2022 - 08/2012
2	AntigensIBA 12/2021 - 09/2012
2	Lenalidomide (CC 5013)FDA Link 01/2021 - 03/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 08/2012
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020 - 08/2012
2	Cytidine DeaminaseIBA 01/2020 - 10/2012
2	LigandsIBA 01/2019 - 07/2014
2	TransferasesIBA 01/2017 - 07/2012
2	CytidineIBA 02/2013 - 10/2012
2	Erythropoietin FDA Link 05/2011 - 01/2000
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 09/2004 - 12/2003
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2024
1	Chimeric Antigen ReceptorsIBA 04/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2024
1	HLA-DR Antigens (HLA-DR)IBA 01/2024
1	micaIBA 01/2024
1	venetoclaxIBA 08/2023
1	enzalutamideIBA 05/2023
1	Cadherins (E-Cadherin)IBA 05/2023
1	Androgen Receptors (Androgen Receptor)IBA 05/2023
1	AndrogensIBA 05/2023
1	guadecitabineIBA 05/2023
1	CateninsIBA 05/2023
1	Interferon Type IIBA 11/2022
1	eltrombopag FDA Link 01/2022
1	Thrombopoietin ReceptorsIBA 01/2022
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2021
1	Protein Disulfide-IsomerasesIBA 05/2021
1	Immunoglobulins (Immunoglobulin)IBA 05/2021
1	pyrimidineIBA 01/2021
1	ProdrugsIBA 01/2021
1	Naphazoline (All Clear)FDA LinkGeneric 01/2021
1	Thioredoxin-Disulfide ReductaseIBA 01/2021
1	SirtuinsIBA 01/2020

Therapy/Procedure

31	Therapeutics 04/2024 - 10/2007
5	Drug Therapy (Chemotherapy) 01/2023 - 02/2011
2	Transplantation 01/2019 - 09/2004